Connect with us

Business

Scotland to Go the Way of Portugal and Calls for the Decriminalization of All Drugs – The War on Drugs is a Failure

Published

on

Scotland has one of the highest overdose rates in the EU, things need to change.

Last week, the Scottish government made a plea to decriminalize the possession of small quantities of drugs as an effort to address the alarming number of overdose deaths in the country, which ranks among the highest in Europe. In a policy proposal, the semi-autonomous government in Edinburgh, led by the Scottish National Party advocating for independence, stated that removing criminal penalties for drug possession would enable the implementation of safe and evidence-based harm reduction services.

During a press conference, Scottish drugs minister Elena Whitham, alongside drug policy reform advocates Helen Clark, the former Prime Minister of New Zealand, and Ruth Dreifuss, the former President of Switzerland, expressed their belief that the “war on drugs” had proven unsuccessful. Whitham emphasised that the current drug legislation not only fails to deter drug use, prevent associated harm, and ultimately save lives, but it also exacerbates the negative consequences experienced by individuals. Criminalisation contributes to fatalities and intensifies the harm caused by drug use.

Scotland’s Urgent Call for Drug Decriminalization Amidst Overwhelming Overdose Crisis

Scotland currently faces a devastating drug overdose crisis, with a death rate three times higher than the rest of the United Kingdom and the highest in Western Europe. Government data cited by the Associated Press revealed that in the previous year, Scotland, with a population of only 5.5 million, witnessed 1,330 fatal drug overdoses.

In response to this alarming situation, the Scottish government published a policy paper last Friday, expressing deep empathy for the families and communities affected by each drug-related death. They acknowledged the urgent need for comprehensive measures and emphasised their consistent stance on adopting a radical public health approach to combat the drug emergency.

Drawing inspiration from Portugal’s drug policy, where criminal penalties were replaced by health-oriented reforms in 2001, the Scottish government proposed a similar decriminalization strategy. They believe such a plan would eliminate the fear of seeking treatment and support, thereby reducing drug-related harm and ultimately improving lives.

Additionally, the government intends to advocate for the establishment of supervised drug consumption sites, which have proven to save lives and encourage individuals struggling with substance misuse to seek assistance. They also put forth the idea of introducing regulated drug supplies to ensure consistency and safety.

Scottish drugs minister Elena Whitham highlighted the urgency of implementing a radical shift in drug policy, expressing concern over the increasing prevalence of synthetic opioids and new street benzodiazepines. She emphasised that without adequate 21st-century drug laws, Scotland would be ill-prepared to face the potential consequences.

Whitham’s apprehension stemmed from the belief that the situation would only worsen unless significant changes were made. The Scottish government aims to confront the crisis head-on by adopting innovative drug policy approaches, ensuring their citizens’ well-being and preventing further harm.

UK Government Stands Firm Against Drug Decriminalization

However, conservatives in both Scotland and the national government of the United Kingdom opposed the proposal for drug decriminalization. In Scotland, the current policy allows individuals caught in possession of drugs to receive a police warning, but complete decriminalization would necessitate approval from the conservative government in London. Max Blain, spokesperson for Prime Minister Rishi Sunak, stated that such approval would not be granted.

Blain asserted, “There are no intentions to modify our firm stance on drugs.” The U.K. Home Office echoed this sentiment in a statement following Scotland’s decriminalization plan, emphasising their commitment to preventing drug use through treatment and recovery support, as well as addressing the supply of illegal drugs as outlined in their 10-year drugs strategy. They firmly stated that there were no plans to decriminalize drugs due to the associated harms, including the risks posed by organised criminals who exploit and engage in violence to further their illicit businesses.

Russell Findlay, the justice spokesperson for the Scottish Conservative Party, criticised the decriminalization proposal, describing it as “madness” to address Scotland’s drug death crisis, the most severe in Europe, by effectively legalising class-A drugs such as heroin and crack. Findlay expressed concern that such a move would increase drug availability on the streets, ultimately jeopardising more lives.

Evaluating the Impact of Drug Decriminalization

The proposal to decriminalize drugs in Scotland has ignited a vigorous and polarising debate among experts, policymakers, and the general public. With passionate arguments on both sides, the potential implications of such a policy change are being closely examined and assessed.

Drug decriminalization supporters presented strong justifications for their position. They argue that eliminating criminal sanctions for drug possession would get rid of the stigma and obstacles that keep people from getting the care they need. According to supporters, decriminalization would lead to better access to support and treatment programs, reducing drug-related harm and advancing public health. Additionally, they contend that this change would free up law enforcement to concentrate on bringing down sophisticated drug trafficking operations and upending organised crime networks.

However, opponents raise valid concerns about the potential risks associated with drug decriminalization. They expressed apprehension that it could increase drug availability and usage, potentially exacerbating the existing drug crisis. Detractors worry that decriminalization might send a misleading message about drug use, normalising or even encouraging substance abuse. Additionally, they voice fears regarding public safety and the potential for an increase in drug-related offences such as theft or violence.

The ongoing discourse and examination of these potential consequences highlight the intricate nature of addressing the drug crisis. It emphasises the requirement for a thorough strategy that carefully balances public health issues, social issues, and the larger influence on society. As the discussion continues, it is essential to carefully weigh the potential advantages and disadvantages of drug decriminalization to choose the most sensible and successful course of action.

Bottom Line

The government’s plea for drug decriminalization in Scotland in an effort to tackle the devastating overdose crisis has ignited a heated debate. While proponents argue that decriminalization would promote public health and access to treatment, opponents express concerns about potential risks and the impact on public safety. The opposing views of the Scottish and UK conservative governments highlight the complexity of addressing the drug crisis. As the discussions continue, finding a balanced and effective solution that prioritises the well-being of individuals remains a crucial challenge.

Source: https://cannabis.net/blog/news/scotland-to-go-the-way-of-portugal-and-calls-for-the-decriminalization-of-all-drugs-the-war-on

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News